11/08/2024
6:17 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
6:10 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
3:30 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:20 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/05/2024
3:21 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:36 PM | Fulgent Genetics (Subject)
Kim Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
6:37 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:34 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
7:22 PM | Fulgent Genetics (Subject)
Hsieh Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024
6:38 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
6:09 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
3:27 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
3:28 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
3:29 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:22 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:22 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:04 PM | Fulgent Genetics (Issuer)
Marsh Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:05 PM | Fulgent Genetics (Issuer)
GROVES REGINA E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:06 PM | Fulgent Genetics (Issuer)
Nohaile Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:29 PM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:22 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:34 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
6:05 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
3:35 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Ming Hsieh Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:26 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:28 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:10 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:11 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:11 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:12 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:08 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Elon Musk has put himself in their crosshairs (Ad) Today, I have another controversial prediction.
One which I will take no pleasure in seeing come true.
See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger. I share with you in this special investigative documentary. |
02/27/2024
5:50 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:52 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:55 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:48 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
6:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
6:26 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:01 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:39 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
7:49 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
8:43 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
5:00 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:47 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:54 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
5:12 PM | Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
5:12 PM | Fulgent Genetics (Subject)
Kim Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
5:13 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
3:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:30 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
8:21 PM | Fulgent Genetics (Subject)
Kim Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
8:21 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
